FDA Announces Recall of GenTeal Tears Lubricant Eye Gel

Alcon Research LLC is recalling its sterile GenTeal Tears Lubricant Eye Gel. The FDA announced the recall on May 6, 2024. The action stems from FDA inspection observations indicating a potential lack of assurance of sterility for this product. Sterility is a required quality for this type of medical gel.

What Consumers Should Do Immediately

Check your medicine cabinet or personal care items. The recalled product is a 10g tube of GenTeal Tears Lubricant Eye Gel, labeled as sterile. Its National Drug Code (NDC) is 0065-8064-01. It was distributed by Alcon Laboratories, Inc. of Fort Worth, Texas.

If you have this product, stop using it. Do not apply it to your eyes. Alcon advises consumers to contact their physician or pharmacist for advice on alternative treatments. You can also contact Alcon directly for instructions on how to return the product. For questions, consumers can call Alcon at 1-800-757-9195.

Health Implications of a Non-Sterile Eye Product

Using a non-sterile product on the eye presents a direct risk of infection. The eye is a sensitive organ with limited defenses against microbial invasion. Contaminated gel could introduce bacteria, fungi, or other pathogens.

Potential consequences include bacterial conjunctivitis (pink eye), keratitis (corneal infection), or more severe ocular infections. These conditions can cause pain, redness, blurred vision, and discharge. In serious cases, they can lead to corneal scarring or permanent vision impairment. For individuals with existing eye conditions, compromised immune systems, or recent ocular surgery, the risk is heightened.

This recall specifically involves the “Sterile” version of GenTeal Tears. Non-sterile lubricant gels, which are common over-the-counter products, carry different manufacturing standards and are not part of this recall. The issue is the failure to meet the specific sterility claim on this product’s labeling.

Why Sterility Assurance Matters in Medical Products

Sterility assurance is a fundamental requirement for any product labeled as sterile. The FDA’s current good manufacturing practice regulations mandate strict controls. These controls cover the entire manufacturing process, from component handling to filling and sealing containers.

The FDA inspection that prompted this recall found observations that could affect product quality. While the agency has not reported specific patient adverse events linked to this batch, the recall is a precautionary measure. It prevents potential exposure to a product that may not meet its stated safety standard.

Such recalls highlight the role of FDA surveillance in maintaining product integrity. They also underscore the importance of consumer vigilance. Always check FDA recall announcements and examine product labels when using medical items.

Source:
FDA Safety Alerts